Science Explorer Interactive view Map

Mundipharma (United Kingdom)

World rank, all time
#24,849
of 42,892
Rank in United Kingdom
#1,325
of 2,253
Research works
209
▼ 31% vs 2013–17
Citations
6.5k
31.0 per fractional work
Top-10% rate
11.3%
record average 16.5%
Open access
45%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.29× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.84× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 2.38× its world share, 1 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 6.16× its world share, 1 worksPharmacology, Toxico…Chemical Engineering: 0.72× its world share, 0 worksChemical EngineeringChemistry: 2.11× its world share, 1 worksChemistryComputer Science: 0.19× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 1.92× its world share, 1 worksEarth and Planetary …Engineering: 0.25× its world share, 1 worksEngineeringEnvironmental Science: 0.35× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.86× its world share, 1 worksMaterials SciencePhysics and Astronomy: 1.35× its world share, 1 worksPhysics and AstronomyHealth Professions: 0.62× its world share, 0 worksHealth ProfessionsMedicine: 2.45× its world share, 16 worksMedicineVeterinary: 3.63× its world share, 0 worksVeterinaryArts and Humanities: 0.38× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.10× its world share, 0 worksBusiness, Management…Decision Sciences: 0.59× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.41× its world share, 1 worksEconomics, Econometr…Psychology: 0.34× its world share, 0 worksPsychologySocial Sciences: 0.32× its world share, 1 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.2×. Every wedge is a field page.

Which keywords describe research at Mundipharma (United Kingdom)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Antifungal Therapy, Breast Cancer, Tumor Microenvironment, Immunocompromised Patients, Candidiasis, Invasive Fungal Infections and Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 39 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 39 words, with their numbers
  1. Epidemiology4▲ 2.8×17 topics
  2. Antifungal Therapy2▲ 66×3 topics
  3. Inflammation2▲ 2.6×8 topics
  4. Breast Cancer2▲ 22×3 topics
  5. Immunocompromised Patients2▲ 87×2 topics
  6. Immunotherapy2▲ 7.0×6 topics
  7. Tumor Microenvironment2▲ 12×3 topics
  8. Candidiasis2▲ 103×1 topic
  9. Invasive Fungal Infections2▲ 127×1 topic
  10. Gene Therapy2▲ 24×4 topics
  11. Synthesis2▲ 12×3 topics
  12. Chemotherapy1▲ 5.9×2 topics
  13. Monoclonal Antibody1▲ 81×2 topics
  14. Tumor Regression1▲ 39×2 topics
  15. Diagnosis1▲ 4.3×8 topics
  16. HER21▲ 140×1 topic
  17. Medicinal Chemistry1▲ 14×2 topics
  18. Monoclonal Antibodies1▲ 45×3 topics
  19. Trastuzumab1▲ 88×1 topic
  20. Treatment1▲ 3.2×9 topics
  21. Cancer1▲ 2.7×6 topics
  22. Entrepreneurship1▲ 9.1×2 topics
  23. Climate Change1▲ 1.18×2 topics
  24. HIF-11▲ 55×1 topic
  25. Intellectual Property1▲ 28×2 topics
  26. Lymphoma1▲ 20×3 topics
  27. Quality of Life1▲ 2.4×4 topics
  28. Warburg Effect1▲ 55×1 topic
  29. Antimicrobial Activity1▲ 18×1 topic
  30. Astrobiology1▲ 104×1 topic
  31. Capacity Building1▲ 51×2 topics
  32. Cost-effectiveness Analysis1▲ 35×1 topic
  33. Extraterrestrial Life1▲ 143×1 topic
  34. Glacier1▲ 69×1 topic
  35. Global Collaboration1▲ 91×1 topic
  36. Health Biotechnology1▲ 198×1 topic
  37. Health Utility Measures1▲ 35×1 topic
  38. Quinoxaline1▲ 142×1 topic
  39. Water Availability1▲ 69×1 topic

Which research topics does Mundipharma (United Kingdom) publish most on?

By volume in 2022–2025: Antifungal resistance and susceptibility, HER2/EGFR in Cancer Research, Cancer, Hypoxia, and Metabolism and Cryospheric studies and observations.

  1. 1 Antifungal resistance and susceptibility Infectious Diseases 2 works
  2. 2 HER2/EGFR in Cancer Research Oncology 1 works
  3. 3 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
  4. 4 Cryospheric studies and observations Atmospheric Science 1 works
  5. 5 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 1 works
  6. 6 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  7. 7 Synthesis and Biological Evaluation Organic Chemistry 1 works
  8. 8 Space Science and Extraterrestrial Life Astronomy and Astrophysics 1 works
  9. 9 CAR-T cell therapy research Oncology 1 works
  10. 10 RNA Interference and Gene Delivery Molecular Biology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.6%not open55.4%

World: 28% of research is openly available.

with international co-authors44.1%domestic only55.9%

World: 19% is written across borders.

How has Mundipharma (United Kingdom)'s research output changed?

Output in 2018–2022 was 31% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.